Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Hospital Oost-Limburg

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Ziekenhuis Oost-Limburg (ZOL) is a major, top-clinical healthcare facility centered at Synaps Park 1, 3600 Genk, Belgium, operating as one of the largest non-university hospital networks in the country. Established in 1995 through regional mergers, the network spans four campuses—including its primary Sint-Jan campus in Genk—and manages over 1,000 beds alongside a dedicated team of roughly 400 doctors and 4,000 professionals. As a highly regarded regional and supraregional care center, ZOL provides highly advanced medical expertise in fields such as robotic surgery, neonatal intensive care, neurosurgery, and comprehensive medical imaging.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Hospital

Business Subcategory

Source: Human-provided. Hospital
Source: Trial-derived.
166Total Trials
Source: Trial-derived.
53Recruiting Trials
Source: Trial-derived.
77Active Trials
Source: Trial-derived.
78Completed Trials
Source: Trial-derived.
238Unique Conditions
Source: Trial-derived.
146Unique Sponsors

Conditions

Source: Trial-derived. Atrial Fibrillation (10)Source: Trial-derived. Heart Failure (7)Source: Trial-derived. Coronary Artery Disease (6)Source: Trial-derived. NAFLD (3)Source: Trial-derived. Peripheral Arterial Disease (3)Source: Trial-derived. Rheumatoid Arthritis (3)Source: Trial-derived. Stroke (3)Source: Trial-derived. Surgery (3)

Sponsors

Source: Trial-derived. Ziekenhuis Oost-Limburg (67)Source: Trial-derived. Hasselt University (23)Source: Trial-derived. Janssen Research & Development, LLC (11)Source: Trial-derived. Jessa Hospital (10)Source: Trial-derived. AbbVie (6)Source: Trial-derived. Boehringer Ingelheim (6)Source: Trial-derived. KU Leuven (6)Source: Trial-derived. Universitaire Ziekenhuizen KU Leuven (5)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. ETDRS 4 m visual-acuity lane
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. Optical coherence tomography (OCT)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Timed pharmacokinetic sampling and processing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Intravitreal injection
Source: AI-inferred. Liver biopsy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Fundus autofluorescence imaging
Source: AI-inferred. Magnetic resonance elastography
Source: AI-inferred. Measurable residual disease (MRD) assessment
Source: AI-inferred. Mesopic microperimetry
Source: AI-inferred. Minimal residual disease testing
Source: AI-inferred. Participant mobile study app (eDiary/ePRO)